Quality management: Unterschied zwischen den Versionen
| Zeile 88: | Zeile 88: | ||
[https://laws-lois.justice.gc.ca/eng/regulations/SOR-2018-144/page-14.html#docCont (source)] | [https://laws-lois.justice.gc.ca/eng/regulations/SOR-2018-144/page-14.html#docCont (source)] | ||
| + | |||
| + | == Regulations Europe == | ||
| + | CPC: Bitte hier EU-GMP Chapter 1 PQS einfügen: | ||
| + | |||
| + | ===EU GMP Guide Chapter 1 Pharmaceutical Quality System=== | ||
| + | https://gmpcadviser.com/index.html?action=infounit&value=RmrY19qUiH&anchorlink=Regulations_C_EU_C03-1-1_xml | ||
Version vom 10. Mai 2021, 10:37 Uhr
Inhaltsverzeichnis
- 1 Regulations Canada
- 1.1 Sanitation program
- 1.2 Testing
- 1.2.1 Sale and exportation — cannabis product
- 1.2.2 Testing for phytocannabinoids
- 1.2.3 Timing of testing
- 1.2.4 Testing for contaminants
- 1.2.5 Timing of testing
- 1.2.6 Tolerance limits
- 1.2.7 Dissolution and disintegration testing
- 1.2.8 Timing of testing
- 1.2.9 Testing method
- 1.2.10 Retention period
- 1.2.11 Sufficient quantity
- 2 Regulations Europe
Regulations Canada
Sanitation program
87 (1) Cannabis and anything that will be used as an ingredient must be produced, packaged, labelled, distributed, stored, sampled and tested in accordance with a sanitation program that sets out
(a) procedures for effectively cleaning the building or part of the building in which those activities are conducted;
(b) procedures for effectively cleaning the equipment and conveyances used in those activities;
(c) procedures for handling any substance used in those activities; and
(d) all requirements, in respect of the health and hygienic behaviour of the personnel who are involved in those activities, that are necessary to ensure that those activities are conducted in sanitary conditions.
Marginal note:Non-application
(2) Paragraph (1)(a) does not apply to the outdoor cultivation, propagation or harvesting of cannabis or anything that will be used as an ingredient.
Testing
Sale and exportation — cannabis product
89 A holder of a licence must not sell or export a cannabis product unless the applicable requirements set out in sections 90 to 92 have been met.
Testing for phytocannabinoids
90 (1) Testing for the quantity or concentration, as the case may be, of THC, THCA, CBD and CBDA must be conducted on each lot or batch of cannabis, other than cannabis plants or cannabis plant seeds, that
(a) is or will become a cannabis product; or
(b) is or will be contained in a cannabis accessory that is or will become a cannabis product.
Timing of testing
(2) The testing must be conducted on the final form of the cannabis, either before or after it — or the cannabis accessory that contains it — is packaged and labelled as a cannabis product.
Testing for contaminants
91 (1) Testing for microbial and chemical contaminants — other than residues of a pest control product or its components or derivatives — must be conducted on
(a) each lot or batch of cannabis — other than cannabis plants, cannabis plant seeds or edible cannabis — that
(i) is or will become a cannabis product, or
(ii) is or will be contained in a cannabis accessory that is or will become a cannabis product; or
(b) each lot or batch of cannabis — other than cannabis plant seeds — that
(i) is used to produce the cannabis referred to in paragraph (a), or
(ii) is used to produce edible cannabis that is or will become a cannabis product, or that is or will be contained in a cannabis accessory that is or will become a cannabis product.
Timing of testing
(2) The testing on a lot or batch of cannabis must be conducted as follows:
(a) the testing referred to in paragraph (1)(a) must be conducted on the final form of the cannabis, either before or after it — or the cannabis accessory that contains it — is packaged and labelled as a cannabis product; and
(b) the testing referred to in paragraph (1)(b) must be conducted after the final step in the production process during which the contaminants referred to in subsection (1) could have been introduced or could be concentrated, whichever is later.
Tolerance limits
(3) The results of the testing referred to in subsection (1) must enable a determination of whether the contaminants, if any, are or will be within the tolerance limits referred to in subsection 93(3) or 94(2) or section 101.1, as the case may be.
Dissolution and disintegration testing
91.1 (1) If cannabis — or a cannabis accessory that contains cannabis — is or will become a cannabis product to which subsection 95(1) applies, testing must be conducted on each lot or batch of the cannabis or cannabis accessory to determine whether the requirements referred to in that subsection are, or will be, met.
Timing of testing
(2) The testing must be conducted on the final form of the cannabis, either before or after it — or the cannabis accessory that contains it — is packaged and labelled as a cannabis product.
Testing method
92 (1) Testing that is conducted under sections 90 to 91.1 — or to determine whether the applicable requirements in Part 6 are, or will be, met — must be conducted using validated methods on a representative sample of each lot or batch of cannabis or cannabis accessory that contains cannabis.
Retention period
(2) A portion of the sample referred to in subsection (1) must be retained for at least one year after the date of the last sale of any portion of the lot or batch.
Sufficient quantity
(3) The portion of the sample retained under subsection (2) must be of sufficient quantity to enable a determination of
(a) whether the lot or batch meets the requirements of section 81, subsection 93(3), 94(2) or 95(1) or section 101.1, as applicable; and
(b) the quantity or concentration of THC, THCA, CBD and CBDA.
Regulations Europe
CPC: Bitte hier EU-GMP Chapter 1 PQS einfügen: